Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 16, 2007
Transfer of autologous gene-modified T cells in HIV-infected patients with advanced immunodeficiency and drug-resistant virusJan van Lunzen, Tobias Glaunsinger, Ingrid Stahmer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 10, 2017
Transfer of Autologous Gene-modified T Cells in HIV-infected Patients with Advanced Immunodeficiency and Drug-resistant VirusJan van Lunzen, Tobias Glaunsinger, Ingrid Stahmer, et al.
AIDS (London, England)|December 20, 2015
Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b studyJan van Lunzen, Andrea Antinori, Calvin J Cohen, et al.
Antimicrobial Agents and Chemotherapy|January 3, 2022
Impact of Integrase Sequences from HIV-1 Subtypes A6/A1 on the <i>In Vitro</i> Potency of Cabotegravir or RilpivirineJerry L Jeffrey, Marty St Clair, Ping Wang, et al.
The Journal of Clinical Investigation|August 28, 2012
Expansion of HIV-specific T follicular helper cells in chronic HIV infectionMadelene Lindqvist, Jan van Lunzen, Damien Z Soghoian, et al.
Journal of Leukocyte Biology|May 28, 2013
Decreased frequency of CD73+CD8+ T cells of HIV-infected patients correlates with immune activation and T cell exhaustionIlona Tóth, Anh Q Le, Philip Hartjen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2024
Risk of Non-AIDS-Defining Events Is Lower in Antiretroviral Therapy (ART)-Naive HIV Controllers Than in Normal Progressors on Suppressive ARTAlbert L Groenendijk, Pedro Miranda Afonso, Ferdinand W N M Wit, et al.
JCI Insight|February 1, 2017
Circulating CXCR5<sup>+</sup>CXCR3<sup>+</sup>PD-1<sup>lo</sup> Tfh-like cells in HIV-1 controllers with neutralizing antibody breadthEnrique Martin-Gayo, Jacqueline Cronin, Taylor Hickman, et al.
Pageof 12